ACP
EIGR

Acuta Capital Partners’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Acuta Capital Partners’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,750
Closed -$2.81M – 56
2020
Q2 		$2.81M Buy
+9,750
New +$2.81M 0.81% 36
2015
Q4 		– Sell
-1,822
Closed -$861K – 66
2015
Q3 		$861K Buy
+1,822
New +$861K 0.5% 43